Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 65 Records) |
| Query Trace: Syndrome and DRD2[original query] |
|---|
| Suicidal behavior and haplotypes of the dopamine receptor gene (DRD2) and ANKK1 gene polymorphisms in patients with alcohol dependence--preliminary report. PloS one 2014 9 (11): e111798. Jasiewicz Andrzej, Samochowiec Agnieszka, Samochowiec Jerzy, Ma?ecka Iwona, Suchanecka Aleksandra, Grzywacz An |
| Association between the traditional Chinese medicine pathological factors of opioid addiction and DRD2/ANKK1 TaqIA polymorphisms. BMC complementary and alternative medicine 2015 15 209. Cai Meimei, Su Zhiyang, Zou Hong, Zhang Qin, Shen Jianying, Zhang Lingyuan, Wang Teng, Yang Zhaoyang, Li Cando |
| Association between DRD2/ANKK1 TaqIA Polymorphism and Susceptibility with Tourette Syndrome: A Meta-Analysis. PloS one 2015 10 (6): e0131060. Yuan Aihua, Su Liang, Yu Shunying, Li Chunbo, Yu Tao, Sun Jinh |
| DRD2 genotypic and haplotype variation is associated with improvements in negative symptoms after 6 weeks' amisulpride treatment. Journal of clinical psychopharmacology 2015 Apr 35 (2): 158-62. Kang Seung-Gul, Na Kyoung-Sae, Lee Heon-Jeong, Chee Ik-Seung, Lee Kwanghun, Lee Jongh |
| Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms. Journal of reward deficiency syndrome 2016 9 1 (2): 75-80. Blum Kenneth, Simpatico Thomas, Badgaiyan Rajendra D, Demetrovics Zsolt, Fratantonio James, Agan Gozde, Febo Marcelo, Gold Mark |
| Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia. Psychiatry research 2016 Apr 240 209-213. Charan Alladi, Shewade Deepak Gopal, Rajkumar Ravi Philip, Chandrasekaran Adith |
| Identification of genetic correlates of response to Risperidone: Findings of a multicentric schizophrenia study from India. Asian journal of psychiatry 2017 Jul 29 174-182. Kaur Gurjit, Gupta Deepti, Chavan Bir Singh, Sinhmar Vikas, Prasad Rajendra, Tripathi Adarsh, Garg P D, Gupta Rajiv, Khurana Hitesh, Gautam Shiv, Margoob Mushtaq Ahmed, Aneja Jitend |
| Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia. Neuropsychiatric disease and treatment 2017 13 2935-2943. Han Jiyang, Li Yan, Wang Xum |
| The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer's in Aging African-Americans. Molecular neurobiology 2017 10 55 (7): 5526-5536. Blum Kenneth, Badgaiyan Rajendra D, Dunston Georgia M, Baron David, Modestino Edward J, McLaughlin Thomas, Steinberg Bruce, Gold Mark S, Gondré-Lewis Marjorie |
| Prevalence of polymorphisms in the ANKK1, DRD2, DRD3 genes and metabolic syndrome in refractory schizophrenia. Revista latino-americana de enfermagem 2018 26 e2983. Pinto Jeizziani Aparecida Ferreira, Freitas Pedro Henrique Batista de, Nunes Fernanda Daniela Dorneles, Granjeiro Paulo Afonso, Santos Luciana Lara Dos, Machado Richardson Miran |
| A DRD2/ANNK1-COMT Interaction, Consisting of Functional Variants, Confers Risk of Post-traumatic Stress Disorder in Traumatized Chinese. Frontiers in psychiatry 2018 9 170. Zhang Kunlin, Wang Li, Cao Chengqi, Li Gen, Fang Ruojiao, Liu Ping, Luo Shu, Zhang Xiangyang, Liberzon Isra |
| Clinical and Genetic Factors Associated with Resistance to Treatment in Patients with Schizophrenia: A Case-Control Study. International journal of molecular sciences 2019 9 20 (19): . Hajj Aline, Obeid Sahar, Sahyoun Saria, Haddad Chadia, Azar Jocelyne, Rabbaa Khabbaz Lydia, Hallit Souhe |
| Effects of a GWAS-Supported Schizophrenia Variant in the DRD2 Locus on Disease Risk, Anhedonia, and Prefrontal Cortical Thickness. Journal of molecular neuroscience : MN 2019 May . Alfimova Margarita V, Kondratyev Nikolay V, Tomyshev Alexander S, Lebedeva Irina S, Lezheiko Tatyana V, Kaleda Vasiliy G, Abramova Lilia I, Golimbet Vera |
| Neurophysiology and genetics of burning mouth syndrome. European journal of pain (London, England) 2019 Feb . Kolkka Marina, Forssell Heli, Virtanen Arja, Puhakka Antti, Pesonen Ullamari, Jääskeläinen Satu |
| 5'UTR polymorphism in the serotonergic receptor HTR3A gene is differently associated with striatal Dopamine D2/D3 receptor availability in the right putamen in Fibromyalgia patients and healthy controls-Preliminary evidence. Synapse (New York, N.Y.) 2019 Dec e22147. Ledermann Katharina, Hasler Gregor, Jenewein Josef, Sprott Haiko, Schnyder Ulrich, Martin-Soelch Chant |
| An epistasis between dopaminergic and oxytocinergic systems confers risk of post-traumatic stress disorder in a traumatized Chinese cohort. Scientific reports 2019 Dec 9 (1): 19252. Zhang Kunlin, Li Gen, Wang Li, Cao Chengqi, Fang Ruojiao, Luo Shu, Liu Ping, Zhang Xiang Ya |
| The effect of rs1076560 (DRD2) and rs4680 (COMT) on tardive dyskinesia and cognition in schizophrenia subjects. Psychiatric genetics 2020 Oct 30 (5): 125-135. Punchaichira Toyanji Joseph, Kukshal Prachi, Bhatia Triptish, Deshpande Smita Neelkanth, Thelma B |
| In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing. Current psychopharmacology 2020 5 9 (1): 7-21. Blum Kenneth, Baron David, Lott Lisa, Ponce Jessica V, Siwicki David, Boyett Brent, Steinberg Bruce, Modestino Edward J, Fried Lyle, Hauser Mary, Simpatico Thomas, Downs Bill W, McLaughlin Thomas, Hajela Raju, Badgaiyan Rajendra |
| Synonymous polymorphism rs201256011 in dopamine receptor type 2 gene is associated with schizophrenia and PANSS score in Pakistani population: A first report. International journal of clinical practice 2020 May e13536. Amir Qurat-Ul-Ain, Hanif Farina, Washdev Washdev, Bilwani Fareena, Usman Simjee Shaba |
| Genotypes of ANKK1 and DRD2 genes and risk of metabolic syndrome and its components: A cross-sectional study on Iranian women. Obesity research & clinical practice 2021 Aug . Aliasghari Fereshteh, Mahdavi Reza, Barati Meisam, Nazm Saba A, Yasari Sepideh, Bonyadi Mortaza, Jabbari Masoum |
| Influence of DRD2 Polymorphisms on the Clinical Outcomes of Opioiddependent Patients on Methadone Maintenance Therapy. Journal of pharmacy & bioallied sciences 2021 4 12 (Suppl 2): S787-S803. Zahari Zalina, Lee Chee Siong, Ibrahim Muslih Abdulkarim, Musa Nurfadhlina, Mohd Yasin Mohd Azhar, Lee Yeong Yeh, Tan Soo Choon, Mohamad Nasir, Ismail Rus |
| Negative symptoms in schizophrenia: correlation with clinical and genetic factors. Pharmacogenomics 2021 4 22 (7): 389-399. Hajj Aline, Hallit Souheil, Chamoun Karam, Sacre Hala, Obeid Sahar, Haddad Chadia, Dollfus Sonia, Khabbaz Lydia Rabb |
| Association of Polymorphism within the Putative miRNA Target Site in the 3'UTR Region of the DRD2 Gene with Neuroticism in Patients with Substance Use Disorder. International journal of environmental research and public health 2022 08 19 (16): . Boro? Agnieszka, ?miarowska Ma?gorzata, Grzywacz Anna, Chmielowiec Krzysztof, Chmielowiec Jolanta, Masiak Jolanta, Paw?owski Tomasz, Larysz Dariusz, Ciechanowicz Andrz |
| The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia. Genes 2022 7 13 (8): . Paderina Diana Z, Boiko Anastasiia S, Pozhidaev Ivan V, Mednova Irina A, Goncharova Anastasia A, Bocharova Anna V, Fedorenko Olga Yu, Kornetova Elena G, Semke Arkadiy V, Bokhan Nikolay A, Loonen Anton J M, Ivanova Svetlana |
| Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index. Journal of personalized medicine 2022 12 12 (11): . Blum Kenneth, Han David, Bowirrat Abdalla, Downs Bernard William, Bagchi Debasis, Thanos Panayotis K, Baron David, Braverman Eric R, Dennen Catherine A, Gupta Ashim, Elman Igor, Badgaiyan Rajendra D, Llanos-Gomez Luis, Khalsa Jag, Barh Debmalya, McLaughlin Thomas, Gold Mark |
| Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome. Journal of ovarian research 2023 8 16 (1): 158. Mutaz Amin, Nicholas Horst, Claudia Gragno |
| Evidence for the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS). Clinical and experimental psychology 2023 8 9 (4): 8-11. Kenneth Blum, Abdala Bowirrat, Igor Elman, David Baron, Panayotis K Thanos, Mark S Gold, Colin Hanna, Milan T Makale, Keerthy Sunder, Nicole Jafari, Foojan Zeine, Kevin T Murphy, Miles Makale, Rajendra D Badgaiy |
| "TO BE OR NOT TO BE" GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS). Psychology research and behavior management 2023 10 16 4287-4291. Kenneth Blum, Panayotis K Thanos, Colin Hanna, Mark S Gold, David Baron, Igor Elm |
| Genome-wide association exploratory studies in individuals with ultra-high risk for schizophrenia in Chinese Han nationality in two years follow-up: A subpopulation study. Asian journal of psychiatry 2024 5 97 104071. Fei Wang, Zhuo-Hui Huang, Ye Ye, Xiao-Yan He, Shi-Bin Wang, Fu-Jun Jia, Cai-Lan H |
| Oligogenic risk score for Gilles de la Tourette syndrome reveals a genetic continuum of tic disorders. Journal of applied genetics 2025 1 . Malgorzata Borczyk, Jakub P Fichna, Marcin Piechota, S?awomir Go?da, Mateusz Zi?ba, Dzesika Hoinkis, Pawe? Ci?szczyk, Michal Korostynski, Piotr Janik, Cezary ?ekanows |
- Page last reviewed:Feb 1, 2024
- Content source: